| SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer AE Sayan, TR Griffiths, R Pal, GJ Browne, A Ruddick, T Yagci, R Edwards, ... Proceedings of the National Academy of Sciences 106 (35), 14884-14889, 2009 | 193 | 2009 |
| Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells N Ozturk, E Erdal, M Mumcuoglu, KC Akcali, O Yalcin, S Senturk, ... Proceedings of the National Academy of Sciences 103 (7), 2178-2183, 2006 | 78 | 2006 |
| Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression ME Avci, O Konu, T Yagci BMC cancer 8 (1), 1-11, 2008 | 48 | 2008 |
| Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays E Oztas, ME Avci, A Ozcan, AE Sayan, E Tulchinsky, T Yagci Experimental and molecular pathology 89 (2), 182-189, 2010 | 45 | 2010 |
| Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α C Ceran, M Cokol, S Cingoz, I Tasan, M Ozturk, T Yagci BMC cancer 12 (1), 1-16, 2012 | 38 | 2012 |
| SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation T Acun, E Oztas, T Yagci, MC Yakicier BMC cancer 11 (1), 1-10, 2011 | 33 | 2011 |
| Germline hMSH2and hMLH1 gene mutations in incomplete HNPCC families Q Wang, F Desseigne, C Lasset, JC Saurin, C Navarro, T Yagci, I Keser, ... International journal of cancer 73 (6), 831-836, 1997 | 25 | 1997 |
| Cancer stem cells in hepatocellular carcinoma T Yagci, M Cetin, PB Ercin Journal of gastrointestinal cancer 48 (3), 241-245, 2017 | 16 | 2017 |
| Assessment of nuclear ZEB2 as a biomarker for colorectal cancer outcome and TNM risk stratification R Sreekumar, S Harris, K Moutasim, R DeMateos, A Patel, K Emo, ... JAMA network open 1 (6), e183115-e183115, 2018 | 13 | 2018 |
| ETS1 is coexpressed with ZEB2 and mediates ZEB2‐induced epithelial‐mesenchymal transition in human tumors I Yalim‐Camci, P Balcik‐Ercin, M Cetin, G Odabas, N Tokay, AE Sayan, ... Molecular carcinogenesis 58 (6), 1068-1081, 2019 | 12 | 2019 |
| Sulfatide mediates attachment of Pseudomonas aeruginosa to human pharyngeal epithelial cells A Yagci, T Yagci, B Sener, Y Suziki, K Ahmed New Microbiologica 30 (2), 167-171, 2007 | 12 | 2007 |
| ROR1 expression and its functional significance in hepatocellular carcinoma cells M Cetin, G Odabas, LR Douglas, PJ Duriez, P Balcik-Ercin, I Yalim-Camci, ... Cells 8 (3), 210, 2019 | 11 | 2019 |
| A monoclonal antibody against DNA binding helix of p53 protein E Yolcu, BS Sayan, T Yağci, R Cetin-Atalay, T Soussi, N Yurdusev, ... Oncogene 20 (11), 1398-1401, 2001 | 11 | 2001 |
| Genomic instability in colorectal cancers in Turkey T Yağci, S Göksel, Ö Doğan, M Ozturk, N Yurdusev International journal of cancer 68 (3), 291-294, 1996 | 10 | 1996 |
| Immunologic status in children with brain tumors and the effect of therapy R Kebudi, I Ayan, E Darendeliler, L Agaoglu, S Ekmekçioglu, T Yagci, ... Journal of neuro-oncology 24 (3), 219-227, 1995 | 10 | 1995 |
| Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors P Balcik-Ercin, M Cetin, I Yalim-Camci, G Odabas, N Tokay, AE Sayan, ... Cellular Oncology 41 (4), 379-393, 2018 | 9 | 2018 |
| Plexin C1 marks liver cancer cells with epithelial phenotype and is overexpressed in hepatocellular carcinoma G Odabas, M Cetin, S Turhal, H Baloglu, AE Sayan, T Yagci Canadian Journal of Gastroenterology and Hepatology 2018, 2018 | 7 | 2018 |
| Immunization with UV-induced apoptotic cells generates monoclonal antibodies against proteins differentially expressed in hepatocellular carcinoma cell lines H Celikkaya, C Ciraci, E Oztas, ME Avci, M Ozturk, T Yagci Hybridoma 26 (2), 55-61, 2007 | 5 | 2007 |
| Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression P Balcik-Ercin, M Cetin, I Yalim-Camci, T Uygur, T Yagci Molecular Biology 54 (1), 75-81, 2020 | 2 | 2020 |
| Behavior of HepG2 liver cancer cells using microfluidic-microscopy: A preliminary study H Karamahmutoglu, M Çetin, T Yağcı, M Elitaş Microfluidics, BioMEMS, and Medical Microsystems XVI 10491, 104910Y, 2018 | 2 | 2018 |
